Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Centrexion Therapeutics Corporation
CNTX | US
2.29
USD-0.22
-8.76%
CNTX | US
Loading StockChartView...
About Centrexion Therapeutics Corporation
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
16/04/2026
Close
2.29
Open
2.51
High
2.52
Low
2.27
Context Therapeutics Inc. a biopharmaceutical company develops products for the treatment of solid tumors in the United States. It develops CLDN6xCD3 bsAb an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia Pennsylvania.
View LessCNTX | US
Risk
82.8
Sharpe
1.93
Luna's Score
42/100
Recommendation
Sell
Luna says (CNTX | US)
What's Working
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
52.9%1 month
82.8%3 months
93.8%6 months
86.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.49
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
1.60
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-20.01M
MarketCap
171.75M
MarketCap(USD)
171.75M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-29.68
Short ratio
3.89
Short perc.
1.64
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.69
Range1M
1.06
Range3M
2.23
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.29
Price X volume
2.13M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 1.60 | 0.53 | Expensive |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.49 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 93.78 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 171.75M | 3.66B | Emerging |
